Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.94
+1.20 (11.17%)
Jan 28, 2026, 12:13 PM EST - Market open
Korro Bio Stock Forecast
KRRO's stock price has decreased by -67.5% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts that cover Korro Bio stock have a consensus rating of "Buy" and an average price target of $61, which forecasts a 410.89% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $147.
Price Target: $61 (+410.89%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Korro Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 3 | 3 | 3 |
| Buy | 3 | 3 | 2 | 1 | 1 | 3 |
| Hold | 0 | 0 | 0 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $22 | Hold → Buy | Upgrades | $22 | +84.25% | Jan 28, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $21 | Hold → Buy | Upgrades | $21 | +75.88% | Jan 28, 2026 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 14, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $85 → $8 | Buy → Hold | Downgrades | $85 → $8 | -33.00% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
5.58M
from 2.27M
Increased by 145.49%
Revenue Next Year
2.00M
from 5.58M
Decreased by -64.14%
EPS This Year
-9.17
from -9.37
EPS Next Year
-7.82
from -9.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.9M | 6.5M | ||||
| Avg | 5.6M | 2.0M | ||||
| Low | 3.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 205.2% | 16.8% | ||||
| Avg | 145.5% | -64.1% | ||||
| Low | 72.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -8.25 | -5.23 | ||||
| Avg | -9.17 | -7.82 | ||||
| Low | -9.51 | -17.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.